Nurix, Gilead extend research term for oncology program by two years for $10 million fee
Bitget2026/10/05 11:03Nurix Therapeutics extended the research term for an undisclosed oncology program under its strategic collaboration with Gilead by two years. Extension marks the second two-year renewal for the program under the 2019 agreement. Nurix will receive a USD 10 million research term extension fee under the amended deal. Nurix can opt into co-development with 50/50 US profit-sharing on up to two programs, subject to restrictions. Deal economics include potential payments of up to about USD 1.3 billion, tied to fees and milestone events. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050700PRIMZONEFULLFEED9838803) on October 05, 2026, and is solely responsible for the information contained therein.
- Nurix Therapeutics extended the research term for an undisclosed oncology program under its strategic collaboration with Gilead by two years.
- Extension marks the second two-year renewal for the program under the 2019 agreement.
- Nurix will receive a USD 10 million research term extension fee under the amended deal.
- Nurix can opt into co-development with 50/50 US profit-sharing on up to two programs, subject to restrictions.
- Deal economics include potential payments of up to about USD 1.3 billion, tied to fees and milestone events.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.
Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Europe Becomes a Safe Haven Amid AI Turbulence! Citi Turns Bullish on European Stocks, Downgrades US Stocks: Low AI Exposure Seen as Key Advantage
Citigroup strategists have downgraded the rating of U.S. stocks and upgraded the rating of European stocks, following the recent market turbulence caused by upheaval in the artificial intelligence industry.
Crypto prices
More
